Consensus Ibnsina Pharma

Equities

ISPH

EGS512O1C012

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-05-18 pm EDT			5-day change	1st Jan Change
2.47 ^EGP	+4.22%		+10.76%	-21.34%

Mar. 03	Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 05	Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	CI

Evolution of the average Target Price on Ibnsina Pharma

Price target over the last 5 years

History of analyst recommendation changes

b7acb9428b2197cfaabfc001.V-r7nFsEthCj2_fgw4WMA63kq7cV4J77cq7AFuRKdRs.Y5-B7hpI8ynQuo7Q-8nmZ52Xm-Z-tP3PB-aXWZMpJHwtmY6kIWfPStuTog~6a1d4f7146aa69445dd2f6c5bfd3931e

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.47 EGP

Average target price

4.632 EGP

Spread / Average Target

+87.55%

High Price Target

5.8 EGP

Spread / Highest target

+134.82%

Low Price Target

4 EGP

Spread / Lowest Target

+61.94%

Consensus detail

Consensus revision (last 18 months)

Ratings for Ibnsina Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar